Correction: Sodium-Glucose Cotransporter-2 Inhibitors versus Glucagon-Like Peptide 1 Receptor Agonists Effects on Kidney and Clinical Outcomes in Veterans with Type 2 Diabetes.
作者信息
Morello Candis M, Awdishu Linda, Lam Stepfanie, Heman Amy, Bounthavong Mark
出版信息
Kidney360. 2025 Jan 1;6(1):177. doi: 10.34067/KID.0000000667.
Abstract
摘要
相似文献
1
Correction: Sodium-Glucose Cotransporter-2 Inhibitors versus Glucagon-Like Peptide 1 Receptor Agonists Effects on Kidney and Clinical Outcomes in Veterans with Type 2 Diabetes.更正：钠-葡萄糖协同转运蛋白2抑制剂与胰高血糖素样肽1受体激动剂对2型糖尿病退伍军人肾脏及临床结局的影响
Kidney360. 2025 Jan 1;6(1):177. doi: 10.34067/KID.0000000667.
2
Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).改善 1 型糖尿病的肥胖治疗（OTID）：胰高血糖素样肽 1 类似物和钠-葡萄糖共转运蛋白 2 抑制剂联合治疗的随机对照试验——改善 1 型糖尿病的肥胖治疗（OTID 试验）方案。
Trials. 2024 Feb 16;25(1):129. doi: 10.1186/s13063-024-07930-3.
3
Primary Occurrence of Cardiovascular Events After Adding Sodium-Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes.与二肽基肽酶-4 抑制剂相比，钠-葡萄糖共转运蛋白 2 抑制剂或胰高血糖素样肽-1 受体激动剂添加后心血管事件的初次发生：一项糖尿病退伍军人队列研究。
Ann Intern Med. 2023 Jun;176(6):751-760. doi: 10.7326/M22-2751. Epub 2023 May 9.
4
Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A population-based cohort study.基于人群队列研究的 2 型糖尿病患者胰高血糖素样肽-1 受体激动剂与钠-葡萄糖共转运蛋白 2 抑制剂的心血管比较效果。
Diabetes Obes Metab. 2022 Aug;24(8):1623-1637. doi: 10.1111/dom.14741. Epub 2022 May 25.
5
Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus.胰高血糖素样肽-1 受体激动剂和钠-葡萄糖共转运蛋白 2 抑制剂对亚洲 2 型糖尿病患者与白人患者心血管和肾脏结局的影响。
Diabetes Metab Syndr. 2023 Jul;17(7):102804. doi: 10.1016/j.dsx.2023.102804. Epub 2023 Jun 2.
6
Sodium-Glucose Cotransporter-2 Inhibitors versus Glucagon-Like Peptide 1 Receptor Agonists Effects on Kidney and Clinical Outcomes in Veterans with Type 2 Diabetes.钠-葡萄糖协同转运蛋白2抑制剂与胰高血糖素样肽1受体激动剂对2型糖尿病退伍军人肾脏及临床结局的影响
Kidney360. 2024 Nov 1;5(11):1633-1643. doi: 10.34067/KID.0000000597. Epub 2024 Oct 3.
7
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for cardiovascular and renal protection: A treatment approach far beyond their glucose-lowering effect.胰高血糖素样肽-1 受体激动剂和钠-葡萄糖共转运蛋白 2 抑制剂在心血管和肾脏保护方面的作用：一种超越降血糖作用的治疗方法。
Eur J Intern Med. 2022 Feb;96:26-33. doi: 10.1016/j.ejim.2021.11.008. Epub 2021 Nov 17.
8
Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes.在 2 型糖尿病中应用胰高血糖素样肽-1 受体激动剂联合钠-葡萄糖协同转运蛋白 2 抑制剂的实用考量和原理。
Can J Diabetes. 2021 Apr;45(3):291-302. doi: 10.1016/j.jcjd.2020.09.005. Epub 2020 Sep 14.
9
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study.钠-葡萄糖共转运蛋白 2 抑制剂和胰高血糖素样肽-1 受体激动剂治疗 2 型糖尿病的一线治疗：成本效益研究。
Ann Intern Med. 2022 Oct;175(10):1392-1400. doi: 10.7326/M21-2941. Epub 2022 Oct 4.
10
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observational Real-Life Study.胰高血糖素样肽-1受体激动剂和钠-葡萄糖协同转运蛋白2抑制剂可改善2型糖尿病患者的肾阻力指数：一项为期26周的前瞻性观察性现实生活研究。
J Diabetes Res. 2025 Feb 10;2025:8182211. doi: 10.1155/jdr/8182211. eCollection 2025.
本文引用的文献
1
Sodium-Glucose Cotransporter-2 Inhibitors versus Glucagon-Like Peptide 1 Receptor Agonists Effects on Kidney and Clinical Outcomes in Veterans with Type 2 Diabetes.钠-葡萄糖协同转运蛋白2抑制剂与胰高血糖素样肽1受体激动剂对2型糖尿病退伍军人肾脏及临床结局的影响
Kidney360. 2024 Nov 1;5(11):1633-1643. doi: 10.34067/KID.0000000597. Epub 2024 Oct 3.
Zotero 插件